RCT of PO sodium bicarbonate in patients with renal transplant to see if impacts stability of renal function - catch up here!
BICAR-ICU the Visual Abstract
Another home run, from Divya Bajpai
This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD. These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, and patients. The guidelines incorporate ADPKD-specific care as well as many general CKD management practice points.
This week, we will celebrate in advance World Kidney Day by discussing the results of OBInutuzumab in active lupus nephritis. The LUNAR trial (rituximab versus placebo) was “almost” positive, but not quite there. Would Obi overpower its cousin ritux? ✨
This week, we will continue with February’s aldosterone leitmotif: do mineralocorticoid receptor antagonists (MRAs) truly blind the diagnostic in unilateral hypraldosteronism? Is this the article the mythbuster? Draw your own conclusions
This week, we will discuss the origins of primary hyperaldosteronism in normotensive patients. Could this undetected anomaly be the cause of idiopathic hypertension and CKD?
RCT of PO sodium bicarbonate in patients with renal transplant to see if impacts stability of renal function - catch up here!
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) June 16, 2023
We bring to you today a treatment suggested (2B) by KDIGO to be beneficial in slowing eGFR decline of non-Transplant patients, and evaluate its evidence in the Tx cohort.
Does NaHCO3 Preserve-Transplant function? 🧵
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/vSgmerzo2o
Another home run, from Divya Bajpai